PCN20 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT TRASTUZUMAB FOR TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER IN THE SAUDI ARABIAN SETTING
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66557-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)66557-6/fulltext
Title :
PCN20 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT TRASTUZUMAB FOR TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER IN THE SAUDI ARABIAN SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66557-6&doi=10.1016/S1098-3015(10)66557-6
First page :
Section Title :
Open access? :
No
Section Order :
392